Gregory Mark Weinhoff
Director of Finance/CFO at CENTESSA PHARMACEUTICALS PLC
Net worth: 3 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Altmeyer | M | 63 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 9 years |
| Bradley Campbell | M | 48 | 18 years | |
| Mike Raab Raab | M | 59 | 20 years | |
| Francesco de Rubertis | M | 54 | 4 years | |
| Samarth Kulkarni | M | 45 | 3 years | |
| Saurabh Saha | M | 47 | 3 years | |
| Antoine Yver | M | 66 | 3 years | |
| Mary Lynne Hedley | M | 61 | 3 years | |
| Kristen K. Sheppard | F | - | 2 years | |
| Brett Zbar | M | 51 | 3 years | |
| Otto Schwarz | M | 68 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 5 years |
| Carol Stuckley | F | 68 | 3 years | |
| Tim F. Howe | M | 66 |
Healthinvest Equity Partners
 Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | 11 years |
| Mathias Hukkelhoven | M | 70 | 2 years | |
| Glenn Sblendorio | M | 68 | 18 years | |
| Wilfred Jaeger | M | 67 |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | 11 years |
| David Chao | M | 56 | 3 years | |
| Patrick Yue | M | - | 1 years | |
| Iqbal Hussain | M | 43 | 3 years | |
| Harris Rotman | M | - | 2 years | |
| April Dovholuk | M | - | 1 years | |
| Pomjin Choi | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| David L. Steffy | M | 80 |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | - |
| Michael Bologna | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| Jeong-Woo Jo | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 5 years |
| Arjun Goyal | M | - | 3 years | |
| Karen Anderson | F | 57 | 2 years | |
| Alex Zisson | M | 54 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| Myles D. Greenberg | M | 56 |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | - |
| Martijn Kleijwegt | M | 69 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 5 years |
| Jeff J. Collinson | M | - |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | - |
| Jeffrey Castelli | M | - | 19 years | |
| Ellie Im | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pavan Cheruvu | M | 42 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 4 years |
| Daphne Quimi | F | 58 | 18 years | |
| John Crowley | M | 57 | 22 years | |
| Vivek Ramaswamy | M | 38 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 3 years |
| David Hung | M | 66 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 years |
| Ilise Lombardo | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 4 years |
| Donald Hayden | M | 68 | 12 years | |
| Alan Roemer | M | 54 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | - |
| Thomas S. Templeman | M | 64 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 4 years |
| John M. McAdam | M | 49 | 4 years | |
| Parag V. Meswani | M | - | 4 years | |
| Kenneth W. Peist | M | 60 | 4 years | |
| Sol Barer | M | 76 | 8 years | |
| Mohan Ganesan | M | 56 | 4 years | |
| Clarence Machado | M | 60 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 years |
| Gavin R. Corcoran | M | 61 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 3 years |
| Christine Cvijic | F | 46 | 2 years | |
| Douglas A. Branch | M | - | - | |
| Samina Bari | M | - | - | |
| Aaron Kantoff | M | 29 | 1 years | |
| Ann Thorell | F | 56 | 1 years | |
| George Bickerstaff | M | 68 | 2 years | |
| Ilan Oren | M | 40 | 5 years | |
| S. Schaeffer | F | 55 | 7 years | |
| Tony Vernon | M | 68 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 years |
| David Palling | M | 70 | - | |
| Alexander E. Barkas | M | 76 | - | |
| Lawrence Olanoff | M | 72 | 2 years | |
| Geoffrey P. Gilmore | M | 58 | 4 years | |
| Marion McCourt | F | 64 | 1 years | |
| James Topper | M | 62 | 11 years | |
| Matt Patterson | M | 52 | 6 years | |
| Senthil Sundaram | M | 46 | 4 years | |
| Javad Shahidi | M | - | - | |
| Gregory MacMichael | M | 68 | 1 years | |
| Peter Lee | M | 47 |
J.H. Whitney Capital Partners, LLC
 J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 2 years |
| Matt Bullard | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 1 years |
| Heather White | F | - | - | |
| Eric Floyd | M | 62 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 2 years |
| Paul Korner | M | 58 | 2 years | |
| Michael Adasczik | M | 50 | 3 years | |
| Gary Pisano | M | 62 | 1 years | |
| Matt Q. Reber | M | - |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | - |
| Jonathan Atkeson | M | 51 |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 3 years |
| David J. Lockhart | M | 62 | 7 years | |
| Robert G. Warden | M | 51 |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 3 years |
| Andrew Shenker | M | 69 | - | |
| Pol Boudes | M | 67 | 4 years | |
| Kenneth J. Valenzano | M | 56 | - | |
| Norman Hardman | M | 78 | 2 years | |
| Myrtle Potter | F | 65 | 2 years | |
| Kathryn Falberg | F | 63 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 years |
| Joseph Michael Warusz | M | 67 | 1 years | |
| J. Ryan Kelly | M | - |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 3 years |
| Jacqualyn Fouse | M | 62 | - | |
| Bruce Ganem | M | - | 4 years | |
| Gregory Licholai | M | 59 | 5 years | |
| Joshua D. Hamermesh | M | 51 | - | |
| Dan Kittredge | M | - |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 2 years |
| James Dentzer | M | 57 | 3 years | |
| Matt Wilson | M | 48 |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 2 years |
| Lawrence T. Friedhoff | M | 75 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | - |
| Olivier Litzka | M | 56 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| Alexander Pasteur | M | 54 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 1 years |
| David Grainger | M | 58 | 3 years | |
| John R. Kirk | M | 67 | - | |
| petra Molan | F | - |
Arvelle Therapeutics BV
 Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 68.00% |
| United Kingdom | 23 | 23.00% |
| Switzerland | 11 | 11.00% |
| Netherlands | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gregory Mark Weinhoff
- Personal Network